Sun Pharmaceutical Industries Limited

NSE: SUNPHARMA

Pharma Pharmaceuticals

₹1,743

-0.90%EOD · 19 Oct

Sun Pharmaceutical Industries Limited is a listed Pharmaceuticals company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹4.18 L Cr

52W Range

₹2047 / ₹1584

Volume

829K

53.9% delivery

1Y Return

+5.3%

P/E Ratio

34.9

P/B Ratio

5.0

ROE

14.7%

Debt / Equity

5.52

Peers in Pharma

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Sun Pharmaceutical Industries Limited(this stock)	₹1,743	₹4.18 L Cr	34.9	5.0	14.7%	0.91%
Cipla LimitedCIPLA	₹1,324.1	₹1.07 L Cr	31.8	3.1	11.7%	0.98%
Dr. Reddy's Laboratories LimitedDRREDDY	₹1,242.5	₹1.03 L Cr	31.0	2.7	8.8%	0.66%
Lupin LimitedLUPIN	₹1,939.2	₹88,678 Cr	16.3	4.0	26.9%	0.91%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

43/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityAverage · 43

ValuationAverage · 45

MomentumAverage · 40

High debt load (D/E 5.5)

Technical Indicators

Full analysis · objective math, not advice

Returns

-0.9%

-1.0%

-5.1%

-10.3%

+4.4%

+5.3%

Weinstein Stage

Stage 3 — Topping (distribution)

RSI (14)

23 Oversold

Trend Template

4/7moderate

RS vs Nifty (3M)

-6.3pp

Moving Averages (price vs MA)

20-DMA

₹1798

below

50-DMA

₹1857

below

150-DMA

₹1841

below

200-DMA

₹1809

below

From 52W High

-14.8%

From 52W Low

+10.1%

Support (20D)

₹1726

Resistance (20D)

₹1880

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+9.0% CAGR

Up 7 of last 11 years

Earnings Quality

Fully cash-backed

OCF / Net Profit = 2.48x · 7/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.